QQ客服 官方微博 反馈留言

	Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial
	Zhang, Yao-Jun; Wang, Xiao-Zeng; Fu, Guosheng; Jing, Quan-Min; Wang, Geng; Jin, Chong-Ying; Xie, Li-Hua; Cai, Jin-Zan; Xu, Bo; Han, Ya-Ling
	2016
卷号	12期号:10页码:1279-1287
关键词	bioresorbable scaffold first-in-man intravascular ultrasound NeoVas optical coherence tomography sirolimus
ISSN号	1774-024X
DOI	10.4244/EIJV12I10A209
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6384633
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zhang, Yao-Jun,Wang, Xiao-Zeng,Fu, Guosheng,et al. Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial[J],2016,12(10):1279-1287.
APA	Zhang, Yao-Jun.,Wang, Xiao-Zeng.,Fu, Guosheng.,Jing, Quan-Min.,Wang, Geng.,...&Han, Ya-Ling.(2016).Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial.,12(10),1279-1287.
MLA	Zhang, Yao-Jun,et al."Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial".12.10(2016):1279-1287.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。